ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2015 American Transplant Congress

    Effect of Everolimus Versus Tacrolimus On Left Ventricular Hypertrophy in Renal Transplant Patients On Maintenance

    J. Morales,1 J. Pascual,2 A. Sánchez-Fructuoso,3 D. Serón,4 J. Díaz,5 F. Oppenheimer,6 M. Rengel,7 D. Hernández,8 J. Cruzado,9 On Behalf of Evita Study Group.

    1Fund. Investigación, H. 12 Octubre, Madrid, Spain; 2S. Nefrología, H. del Mar, Barcelona, Spain; 3S. Nefrología, H. Clínico San Carlos, Madrid, Spain; 4S. Nefrología, H. Vall Hebrón, Barcelona, Spain; 5S. Nefrología, Fund. Puigvert, Barcelona, Spain; 6Unidad Trasp. Renal, H. Clínic i Provincial Barcelona, Barcelona, Spain; 7S. Urología, H. Gregorio Marañón, Madrid, Spain; 8S. Nefrología, H. Carlos Haya, Málaga, Spain; 9S. Nefrología, H. Bellvitge. IDIBELL, Barcelona, Spain.

    PURPOSE: To compare the efficacy of everolimus (EVL) in improving LVH in a regimen with mycophenolic acid (MPA) vs tacrolimus (TAC)+MPA in maintenance renal transplant…
  • 2015 American Transplant Congress

    Efficacy of Sofosbuvir Based Therapy for Recurrent Hepatitis C After Liver Transplantation

    A. Weick,1 K. George,1 S.-M. Jafri,2 D. Moonka.2

    1Internal Medicine, Henry Ford Hospital, Detroit, MI; 2Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, MI.

    Purpose: Evaluate outcomes of sofosbuvir-based hepatitis C therapy in liver transplant patients in a single center clinical setting, including interferon-free regimens.Methods: All patients with history…
  • 2015 American Transplant Congress

    Clinical Utility of Allospecific CD154+T-Cells in Children With Liver Or Intestine Transplantation (LTx, ITx)

    K. Soltys, G. Bond, G. Mazariegos, C. Ashokkumar, K. Dirling, L. O'Toole, P. Kachmar, T. Hartle, D. Martin, C. Trautz, R. Sindhi.

    Hillman Center for Pediatric Transplantation, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA.

    Background: Allospecific CD154+T-cytotoxic memory (CD154+TcM) have completed investigational evaluation as predictors of acute cellular rejection in children with LTx or ITx.Purpose: To evaluate CD154+TcM** as…
  • 2015 American Transplant Congress

    Declaring a Patient Brain Dead on Extracorporeal Membrane Oxygenation (ECMO): Are There Guidelines or Misconceptions?

    K. Kreitler,1 N. Cavarocchi,1 H. Hirose,1 S. West,2 R. Hasz,2 M. Ghobrial,3 R. Bell.3

    1Department of Surgery, Thomas Jefferson University Hospital, Philadelphia, PA; 2Gift of Life Donor Program, Philadelphia, PA; 3Department of Neurology, Thomas Jefferson University Hospital, Philadelphia, PA.

    Purpose: With the rapid growth of ECMO and the accumulating evidence that organs from ECMO donors can be safely transplanted, we reviewed the practice variations…
  • 2015 American Transplant Congress

    Primary and Secondary Vaccine Responses in a Non-Human Primate Model of Cardiac Allotransplantation

    S. Dahi,1 E. Kang,1 T. Zhang,1 B. Vanhove,2 A. Azimzadeh,1 R. Pierson III.1

    1Department of Surgery, University of Maryland School of Medicine, Baltimore, MD; 2INSERM, Nantes, France.

    Purpose: To compare the effect of calcineurin- versus costimulation-based immunosuppression on primary and secondary vaccine responses in non-human primate heart transplant recipients.Background: Antibody response following…
  • 2015 American Transplant Congress

    Donor Specific Tolerance Can Be Induced by Donor Bone Marrow Transfer With Activation of Invariant Naturel Killer T Cells

    S. Miyairi,1 T. Hirai,1 R. Shibahara,1 K. Omoto,1 S. Nunoda,2 K. Yamazaki,2 Y. Ishii,3 K. Tanabe.1

    1Urology, Tokyo Women's Medical University, Shinjuku, Tokyo, Japan; 2Cardiovascular Surgery, Tokyo Women's Medical University, Shinjuku, Tokyo, Japan; 3Laboratory of Vaccine Design, RIKEN IMS-RCAI, Yokohama, Japan.

    It has been reported that liposomal formulation of a-galactosylceramide(lipo-aGC) could induce antigen specific regulatory T cells (Treg) in vivo when administered with particular antigens. We…
  • 2015 American Transplant Congress

    Cell Type of the Tolerizing Inoculum Plays a Role in the Formation of of Molecular Chimerism in Murine Neonatal Tolerance

    X. Wang,1 H. Mewhort,1 S. Wang,1 S. Tollenaar,1 K. Tao,1 L. West.1,2,3

    1Department of Pediatrics, University of Alberta, Edmonton, AB, Canada; 2Department of Surgery, University of Alberta, Edmonton, AB, Canada; 3Alberta Transplant Institute, University of Alberta, Edmonton, AB, Canada.

    Background: Heart transplantation is a lifesaving measure for many infants with severe congenital heart diseases. The acceptance of cardiac allografts without immunosuppression, or operational tolerance,…
  • 2015 American Transplant Congress

    Everolimus With Low Dose Tacrolimus in Intestinal Transplantation

    T. Beduschi, J. Garcia, J. Lugo-Baruqui, J. Fan, S. Nishida, J. Jebrock, A. Tekin, G. Selvaggi, P. Ruiz, R. Vianna.

    Miami Transplant Institute, University of Miami Miller School of Medicine, Miami, FL.

    Introduction: Renal dysfunction is a well-known complication after organ transplant given immunosuppression (ISP) with calcineurin inhibitors. This is especially true after intestinal transplant (ITx) given…
  • 2015 American Transplant Congress

    Does Prophylaxis Strategy Matter? CMV Reactivation in Moderate Risk (R+) Heart Transplant Recipients

    E. Liu, C. Doligalski.

    Pharmacy, Tampa General Hospital, Tampa, FL.

    Purpose: CMV is a significant complication in heart transplant recipients (HTR). Little evidence exists to guide prophylaxis in moderate risk (R+) patients.Methods: An IRB-approved review…
  • 2015 American Transplant Congress

    Assessment of Renal Function in Kidney Transplant Recipients Through Therapeutic Drug Monitoring of Vancomycin

    A. Thamer, N. Elias, C. Varughese, T. Gift, J. Fishman, S. Shao.

    Massachusetts General Hospital, Boston, MA.

    Background: Determining the dose of renally eliminated drugs such as vancomycin in kidney transplant recipients is often challenging due to unclear tools to assess renal…
  • « Previous Page
  • 1
  • …
  • 48
  • 49
  • 50
  • 51
  • 52
  • …
  • 170
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences